Pandemic Influenza Plan - Questar III

Section 6: Vaccine Procurement, Distribution, and Use
3. Vaccine Safety Monitoring
Interpandemic and Pandemic Alert Periods
State Health Department:
• Establish an adverse event monitoring system.
• Designate an adverse event coordinator.
• Monitor adverse events if pre-pandemic vaccine is used.
• Consider how vaccine efficacy studies would be conducted and coordinate
within DOH, especially with researchers and Wadsworth laboratories.
• Disseminate information to LHDs and health care partners on the adverse
event monitoring system.
• Identify those health care providers that would provide medical
consultation on adverse events on the state level.
• Consider how the implementation of active surveillance would be done.
• Plan for the use of an IND or Emergency Use Authorization protocol is
needed.
Local Health Departments:
• Establish an adverse event monitoring system based on the requirements
of the statewide system.
• Identify which staff would be responsible for adverse event monitoring.
• Identify which staff would provide medical consultation for adverse
events on the local level.
• Disseminate information on the adverse event monitoring system to local
health care partners.
• Work with the NYSDOH to plan for IND or Emergency Use
Authorization protocols.
Healthcare Partners:
• Establish an adverse event monitoring system within health care facilities
and practices.
• Identify staff that would be responsible for adverse event monitoring.
• Identify staff that would be responsible for medical consultation for
adverse events.
• Disseminate information on adverse event monitoring to staff.
• Work with NYSDOH and LHDs to plan for IND or Emergency Use
Authorization protocols.
February 7, 2006 6-10